Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Alinwell
CoreAge Rx and Alinwell both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxAlinwell
Ranked #185 · Grade C
Best for: Someone who wants a program written for women and will price tirzepatide at $349 rather than at the figure on the card.
Visit AlinwellThe verdict
CoreAge Rx edges out Alinwell on the Rx-Readiness Score, 95 to 54 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Alinwell is still a genuine option — built for women, and priced one tier below what it charges. The banner offers "GLP-1 weight care for women from $149/mo" and no program costs $149; the tirzepatide card says from $199, which is really the semaglutide rate. Alinwell's own program catalog reads $199 semaglutide, $249 microdose, $349 tirzepatide — so budget $349 for the dual agonist, $150 above the card. The microdose track, the usual route to a smaller bill, is $50 a month more than standard semaglutide. On the credit side it names its operating company plainly, Alinwell LLC, and holds the rate flat once you are on a program. Two pieces of social proof, a 4.8 Trustpilot score and a 4.9 Google rating, could not be matched to any profile. No state list, no compounding pharmacy, and no stated time to first dose. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Alinwell |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 54/100 · C |
| Overall rank | #1 | #185 |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $149/mo | $349/mo |
| Coverage | All 50 states | Not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Alinwell
Ranked #185 · Grade C
What we like
- Built and written for women specifically
- Names its operating company, Alinwell LLC, in its own terms
- Flat rate once you are on a program
The caveats
- Every advertised price is one tier below the real one
- Tirzepatide is marketed at $199 and priced at $349
- The microdose program costs $50 a month more than standard semaglutide
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Alinwell against other providers on our shortlist.
Or browse the full comparison hub.